CLINICAL_TRIALS
trial_result
· 2021-05-25
Clinical Trial Update: A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia [Phase 1]
Summary
Phase 1 study evaluating LY3202328 in overweight healthy participants with dyslipidemia has completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Dyslipidemias | Phase 1 | Status: COMPLETED | Results posted: 2021-05-25